Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022Found: oral 4 0 Oral soft tissue swelling and oedema Lip swelling 27 0 Mouth swelling 7 0 Pancreatic
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022Found: Date: 20-Jan-2004 MedDRA Version: MedDRA 25.1 Reaction Name TotalFatal Gastrointestinal disorders Pancreatic
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 29 August 2022Found: taking zo nisamide who develop the clinical signs and symptoms of pancreatitis, it is recommended that pancreatic
Mentions:
1: Lord Dubs (Lab - Life peer) We are talking about drugs for the treatment of cancer and comments from the pharmaceutical industry - Speech Link
2: Lord Cunningham of Felling (Lab - Life peer) I am sorry; will the noble Lord please focus on pancreatic cancer and say whether he is satisfied with - Speech Link
3: Lord Markham (Con - Life peer) My noble friend Lord Moylan has also raised pancreatic cancer a number of times. - Speech Link
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make it her policy to develop a specific strategy on (a) research, (b) early diagnosis and (c) treatment for less survivable cancers.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
We currently do not have such plans. Making improvements across different cancer types is critical to helping achieve the NHS Long Term Plan ambition of diagnosing 75% of patients at an early stage by 2028 and reducing inequalities in cancer survival. Through NHS England, the Government is taking steps to improve outcomes for cancer patients, including those with less survivable cancers.
The planned Major Conditions Strategy will look at the early diagnosis and treatment of cancer. The Strategy will look at a wide range of interventions and enablers to improve outcomes and experience for a range of cancer patients.
NHS England has commissioned new cancer clinical audits covering five cancer types, some of which are less survivable: pancreatic cancer, ovarian cancer, non-Hodgkin lymphoma, kidney cancer and primary and metastatic breast cancer. All five audits will cover care delivered in England and Wales and will see an investment of approximately £5.4 million for an initial period of three years.
The NHS ‘Help Us, Help You’ (HUHY) cancer campaigns increase awareness of cancer symptoms and encourage people to get checked. Some campaigns focus on specific symptoms linked to less survivable cancers, such as the HUHY abdominal and urological symptoms campaign, while others focus on fear as a barrier to help-seeking, which is relevant to all cancer types.
Jan. 10 2024
Source Page: Authorised Aquaculture Production Businesses and Authorised Processing Establishments: registersFound: Infectious pancreatic necrosis="5." & G$1& ".5."Infectious pancreatic necrosis="5." & J$1& ".5."
Jan. 10 2024
Source Page: Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027Found: Pioglitazone • Risk of fluid retention and congestive heart failure • Risk of bone fractures and bladder cancer
Oral Evidence Jan. 09 2024
Inquiry: Future cancerFound: We will focus on pancreatic cancer, brain cancer and respiratory cancers, including lung cancer and
Asked by: Baillie, Jackie (Scottish Labour - Dumbarton)
Question
To ask the Scottish Government what its response is to reports that women in the west of Scotland have experienced considerable delays in accessing ovarian cancer surgery.
Answered by Minto, Jenni - Minister for Public Health and Women's Health
The Scottish Government is aware of instances of women who have faced significant delays in accessing ovarian cancer surgery in the west of Scotland. Due to the multidisciplinary nature of the surgery for ovarian cancer, scheduling can be challenging for health boards. NHS Greater Glasgow and Clyde (GGC) has advised that action is being taken to simplify scheduling of these cases and thus reduce delays.
Actions taken have included increasing dedicated theatre capacity and improving joint working across surgical teams. The health board is working to increase dedicated time for surgeons from the colorectal, urology, plastic and hepato-pancreatic biliary teams to operate jointly with gynaecology oncology. The surgical team is now bigger, with further training in hand. There has been an increase in weekly operating lists and planning continues to improve around increased access to other surgical specialties.
The Centre for Sustainable Delivery is leading improvement work and pathway redesign via their clinically led specialty delivery group (SDG) for gynaecology. This includes in-depth peer review meetings involving all Boards in NHS Scotland to ensure gynaecology patients are on the right pathway at the right time, supporting improvements in waiting times and patient outcomes.
The Scottish Cancer Network will be establishing a new National Ovarian Cancer Clinical Network, which will work to ensure equity of access to treatment for all women with ovarian cancer in Scotland.
Asked by: Andrew Rosindell (Conservative - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help improve the diagnosis (a) rates and (b) treatments for ovarian cancer in (i) England and (ii) Romford constituency.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Improving the diagnosis rate and treatment for all cancers including for ovarian cancer, is a priority for this Government. The Department is working with NHS England and is taking steps across England to increase diagnosis rates, including setting stretching ambitions, supporting general practitioners (GPs) in referring patients, expanding diagnostic capacity and enabling more precise diagnosis through technology. These steps and actions apply in Romford as across England.
To encourage people to see their general practitioner if they notice symptoms that could be cancer, NHS England runs the ‘Help Us, Help You’ campaigns, which address the barriers that deter patients from accessing the National Health Service. NHS England is currently running a ‘Help us Help you’ campaign highlighting the abdominal and urological symptoms of cancer, including ovarian cancer, and addressing the barriers that stop people from accessing services in the NHS.
NHS England introduced the Faster Diagnosis Standard (FDS) which aims to ensure patients have cancer diagnosed or ruled out within 28 days of urgent referral from a GP or screening services with a 75% standard ambition. To achieve the FDS, NHS England has implemented ‘non-specific symptom pathways’ for patients who have symptoms that do not align to a particular type of tumour, including for non-specific symptoms of pancreatic cancer.
Further to this, the Department has committed to £2.3 billion of capital funding to expanding diagnostic capacity across the NHS by rolling out more community diagnostic centres, delivering vital tests, scans and checks, including for ovarian cancer.
The Department invests in health research through the National Institute for Health and Care Research (NIHR). NIHR has funded six research projects into screening for ovarian cancer since 2018, with a combined total funding value of £3.8 million, including looking at the impact and effectiveness of different kinds of testing and screening and effectiveness of treatment options. The overall goal is to improve diagnosis and treatment to improve patient outcomes.